Transmission and spreading of tauopathy in transgenic mouse brain

Clavaguera, Florence, Bolmont, Tristan, Crowther, R. Anthony, Abramowski, Dorothee, Frank, Stephan, Probst, Alphonse, Fraser, Graham, Stalder, Anna K. +5 more·2009·Nature Cell Biology
DOI 10.1038/ncb1901

Cited by (1,006)

Items 801–900 of 1,006

  1. Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer’s Disease
    Spilman, Patricia R., Corset, Veronique, Gorostiza, Olivia, Poksay, Karen S., Galvan, Veronica, Zhang, Junli, Rao, Rammohan, Peters-Libeu, Clare, Vincelette, Jon, McGeehan, Andrew et al. · 2016 · Journal of Alzheimer's Disease
  2. Regional vulnerability and spreading of hyperphosphorylated tau in seeded mouse brain
    Detrez, Jan R., Maurin, Hervé, Van Kolen, Kristof, Willems, Roland, Colombelli, Julien, Lechat, Benoit, Roucourt, Bart, Van Leuven, Fred, Baatout, Sarah, Larsen, Peter et al. · 2019 · Neurobiology of Disease
  3. Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study
    Holland, Negin, Malpetti, Maura, Rittman, Timothy, Mak, Elijah E, Passamonti, Luca, Kaalund, Sanne S, Hezemans, Frank H, Jones, P Simon, Savulich, George, Hong, Young T et al. · 2022 · Brain
  4. Neurodegenerative Microbially-Shaped Diseases: Oxidative Stress Meets Neuroinflammation
    Diana Filipa Silva, Nuno Empadinhas, Sandra M. Cardoso, A. Raquel Esteves · 2022 · Antioxidants
  5. Impact of N-tau on adult hippocampal neurogenesis, anxiety, and memory
    Andrea Pristerà, Daniele Saraulli, Stefano Farioli Vecchioli, Georgios Strimpakos, Marco Costanzi, Maria Grazia Di Certo, Sara Cannas, Maria Teresa Ciotti, Felice Tirone, Elisabetta Mattei et al. · 2013 · Neurobiology of Aging
  6. Emerging Diagnostic and Therapeutic Strategies for Tauopathies
    David G. Coughlin, David John Irwin · 2017 · Current Neurology and Neuroscience Reports
  7. Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases
    Daniela Sarnataro · 2018 · International Journal of Molecular Sciences
  8. Distinct Conformations, Aggregation and Cellular Internalization of Different Tau Strains
    Thomas K. Karikari, David A. Nagel, Alastair I. Grainger, Charlotte Clarke-Bland, James A Crowe, Eric James Hill, Kevin G. Moffat · 2019 · Frontiers in Cellular Neuroscience
  9. Frontrunner in Translation: Progressive Supranuclear Palsy
    Ali Shoeibi, Nahid Olfati, Irene Litvan · 2019 · Frontiers in Neurology
  10. Seed-competent tau monomer initiates pathology in a tauopathy mouse model
    Hilda Mirbaha, Dailu Chen, Vishruth Mullapudi, Sandi Jo Terpack, Charles L. White, Łukasz A. Joachimiak, Marc I. Diamond · 2022 · Journal of Biological Chemistry
  11. Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models
    Thomas Wısnıewskı, Allal Boutajangout · 2009 · Brain Structure and Function
  12. Neurological characterization of mice deficient in GSK3α highlight pleiotropic physiological functions in cognition and pathological activity as Tau kinase
    Hervé Maurin, Benoit Lechat, Ilse Dewachter, Laurence Ris, Justin Vijay Louis, Peter Borghgraef, Herman Devijver, Tomasz Jaworski, Fred VAN LEUVEN · 2013 · Molecular Brain
  13. Lung endothelium, tau, and amyloids in health and disease
    Ron Balczon, Mike T. Lin, Sarah B. Voth, Amy R. Nelson, Jonas C. Schupp, Brant M. Wagener, Jean‐François Pittet, Troy Stevens · 2023 · Physiological Reviews
  14. Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer's disease
    Doris Lambracht‐Washington, Roger N. Rosenberg · 2013 · ImmunoTargets and Therapy
  15. Prion-Like Propagation of Protein Aggregation and Related Therapeutic Strategies
    Sarah K. Kaufman, Marc I. Diamond · 2013 · Neurotherapeutics
  16. Reversible Cation-Selective Attachment and Self-Assembly of Human Tau on Supported Brain Lipid Membranes
    Stefania Anna Mari, Susanne Wegmann, Katharina Tepper, Bradley T. Hyman, Eva‐Maria Mandelkow, Eckhard Mandelkow�, Daniel J. Müller · 2018 · Nano Letters
  17. Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies
    Salvatore Spina, Jesse A. Brown, Jersey Deng, Raquel C. Gardner, Alissa L. Nana, Ji-Hye L Hwang, Stephanie E. Gaus, Eric Jinsheng Huang, Joel H. Kramer, Howie J. Rosen et al. · 2019 · Brain
  18. Red Ginseng Inhibits Tau Aggregation and Promotes Tau Dissociation In Vitro
    Soo Jung Shin, Yong Ho Park, Seong Gak Jeon, Sujin Kim, Yunkwon Nam, Sang‐Muk Oh, Yong Yook Lee, Minho Moon · 2020 · Oxidative Medicine and Cellular Longevity
  19. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification
    Airi Tarutani, Haruka Miyata, Takashi Nonaka, Kazuko Hasegawa, Mari Yoshida, Yuko Saito, Shigeo Murayama, Andrew Robinson, David M. A. Mann, Taisuke Tomita et al. · 2021 · Brain
  20. PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding
    Alberto Carpinteiro Soares, Andreia Ferreira, Jonas Mariën, Charlotte Delay, Edward B. Lee, John Q. Trojanowski, Dieder Moechars, Wim G. Annaert, Louis De Muynck · 2021 · Journal of Biological Chemistry
  21. Bayesian Physics-Based Modeling of Tau Propagation in Alzheimer's Disease
    Amelie Schäfer, Mathias Peirlinck, Kevin Linka, Ellen Kuhl A, The Alzheimer's Disease Neuroimaging Initiative (ADNI) · 2021 · Frontiers in Physiology
  22. Evidence for Prion-Like Mechanisms in Several Neurodegenerative Diseases: Potential Implications for Immunotherapy
    Kristen Marciniuk, Ryan Taschuk, Scott Napper · 2013 · Clinical and Developmental Immunology
  23. Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord
    Jennifer A. Macdonald, Iraad F. Bronner, Lesley F. Drynan, Juan Fan, Annabelle Curry, Graham Mathew Fraser, Isabelle Lavenir, Michel Goedert · 2019 · Acta Neuropathologica Communications
  24. Tau proteinopathies and the prion concept
    2020 · Progress in Molecular Biology and Translational Science
  25. mNos2Deletion and HumanNOS2Replacement in Alzheimer Disease Models
    Carol A. Colton, Joan G. Wilson, Angela L. Everhart, Donna M. Wilcock, Jukka T. Puoliväli, Taneli Heikkinen, Juho Oksman, Olli Jääskeläinen, Kimmo K Lehtimäki, Teemu Laitinen et al. · 2014 · Journal of Neuropathology & Experimental Neurology
  26. Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence Imaging
    Masafumi Shimojo, Makoto Higuchi, Tetsuya Suhara, Naruhiko Sahara · 2015 · Frontiers in Neuroscience
  27. Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease
    Hasan A. M. M. Almansoub, Hui Ru Tang, Ying Wu, Ding‐Qi Wang, Yacoubou Abdoul Razak Mahaman, Na Wei, Yusra A. M. Almansob, Wei He, Dan Liu · 2018 · Journal of Alzheimer s Disease
  28. What is strain in neurodegenerative diseases?
    Ye Tian, Lanxia Meng, Zhentao Zhang · 2019 · Cellular and Molecular Life Sciences
  29. The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
    Jing Di, Ibrar Ahmed Siddique, Zizheng Li, Ghattas J. Malki, Simon Hornung, Suman Dutta, Ian Hurst, Ella Ishaaya, Austin Wang, Sally Tu et al. · 2021 · Alzheimer s Research & Therapy
  30. The potential role of glial cells in driving the prion-like transcellular propagation of tau in tauopathies
    Zein Amro, Andrea J. Yool, Lyndsey E. Collins‐Praino · 2021 · Brain Behavior & Immunity - Health
  31. Animal Models for Alzheimer’s Disease and Frontotemporal Dementia: A Perspective
    Jürgen Götz, Naeman N. Götz · 2009 · ASN NEURO
  32. Amino acid composition predicts prion activity
    Fayyaz Minhas, Eric D. Ross, Asa Ben‐Hur · 2017 · PLoS Computational Biology
  33. Prion Properties of SOD1 in Amyotrophic Lateral Sclerosis and Potential Therapy
    Caroline Sibilla, Anne Bertolotti · 2017 · Cold Spring Harbor Perspectives in Biology
  34. Cellular mechanisms responsible for cell-to-cell spreading of prions
    Didier Vilette, Josquin Courte, Jean‐Michel Peyrin, Laurent Coudert, Laurent Schaeffer, Olivier Andréoletti, Pascal Leblanc · 2018 · Cellular and Molecular Life Sciences
  35. Pathological Alterations of Tau in Alzheimer’s Disease and 3xTg-AD Mouse Brains
    Longfei Li, Yanli Jiang, Wen Hui Hu, Yunn Chyn Tung, Chun‐Ling Dai, Dandan Chu, Cheng‐Xin Gong, Khalid Iqbal, Fei Liu · 2019 · Molecular Neurobiology
  36. Pneumonia initiates a tauopathy
    Ron Balczon, Mike T. Lin, Ji Lee, Adeel Ahmed Abbasi, Phoibe Renema, Sarah B. Voth, Chun Zhou, Anna Koloteva, C. Michael Francis, Neel Raj Sodha et al. · 2021 · The FASEB Journal
  37. Oxidative stress and Rho GTPases in the biogenesis of tunnelling nanotubes: implications in disease and therapy
    Abinaya Raghavan, Pooja Rao, Jiřı́ Neužil, Dean L. Pountney, Sangeeta Nath · 2021 · Cellular and Molecular Life Sciences
  38. Cisphosphorylated tau as the earliest detectable pathogenic conformation in Alzheimer disease, offering novel diagnostic and therapeutic strategies
    Kazuhiro Nakamura, Xiao Zhen Zhou, Kun Ping Lu · 2013 · Prion
  39. Modelling female physiology from head to Toe: impact of sex hormones, menstrual cycle, and pregnancy
    Abo, Stéphanie, Smith, Delaney, Stadt, Melissa, Layton, Anita · 2022 · Journal of Theoretical Biology
  40. Aggregation, Transmission, and Toxicity of the Microtubule-Associated Protein Tau: A Complex Comprehension
    Jiaxin Hu, Wenchi Sha, Shuangshuang Yuan, Jiarui Wu, Yunpeng Huang · 2023 · International Journal of Molecular Sciences
  41. Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration
    Wen Li, Jiayi Li · 2024 · Translational Neurodegeneration
  42. Sources of Extracellular Tau and its Signaling
    Jesús Ávila, Diana Simón, Miguel Dı́az-Hernández, Jesús J. Pintor, Félix Hernández · 2014 · Journal of Alzheimer s Disease
  43. Convergent Replication of Mouse Synthetic Prion Strains
    Sina Ghaemmaghami, David W. Colby, Hoang-Oanh B. Nguyen, Shigenari Hayashi, Abby Oehler, Stephen J. DeArmond, Stanley B. Prusiner · 2013 · American Journal Of Pathology
  44. Relevance of host tau in tau seeding and spreading in tauopathies
    Isidró Ferrer, María Victoria Zelaya, Meritxell Aguiló, Margarita Carmona, Irene López‐González, Pol Andrés‐Benito, Laia Lidón, Rosalina Gavı́n, Paula Garcia‐Esparcia, José Antonio del Rı́o · 2019 · Brain Pathology
  45. Kinetics of α-synuclein prions preceding neuropathological inclusions in multiple system atrophy
    Amanda L. Woerman, Smita S. Patel, Sabeen A. Kazmi, Abby Oehler, Jisoo Lee, Daniel A. Mordes, Steven H. Olson, Stanley B. Prusiner · 2020 · PLoS Pathogens
  46. Tau Seeding Mouse Models with Patient Brain-Derived Aggregates
    Aiko Robert, Michael Schöll, Thomas Vogels · 2021 · International Journal of Molecular Sciences
  47. Tau Post-Translational Modifications: Potentiators of Selective Vulnerability in Sporadic Alzheimer’s Disease
    Trae Carroll, Sanjib K Guha, Keith W. Nehrke, Gail V.W. Johnson · 2021 · Biology
  48. How it all Started: Tau and Protein Phosphatase 2A
    Chang Liu, Jürgen Götz · 2013 · Journal of Alzheimer s Disease
  49. Tauons and Prions: Infamous Cousins?
    Petr Novák, Michal Prčina, Eva Kontseková · 2011 · Journal of Alzheimer s Disease
  50. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis
    Florent Laferrière, Magdalini Polymenidou · 2015 · Swiss Medical Weekly
  51. Neurophysiological assessment of neural network plasticity and connectivity: Progress towards early functional biomarkers for disease interception therapies in Alzheimer’s disease
    Callum Walsh, Wilhelmus H. I. M. Drinkenburg, Abdallah Ahnaou · 2016 · Neuroscience & Biobehavioral Reviews
  52. In vivo network models identify sex differences in the spread of tau pathology across the brain
    Shokouhi, Sepideh, Taylor, Warren D., Albert, Kimberly, Kang, Hakmook, Newhouse, Paul A., The Alzheimer's Disease Neuroimaging Initiative · 2020 · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
  53. “Prion-like” seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders
    Silvia Zampar, Sonja E. Di Gregorio, Gustavo Grimmer, Joel C. Watts, Martin Ingelsson · 2024 · Frontiers in Neuroscience
  54. Immunotherapy for Tauopathies
    Jiaping Gu, Einar M. Sigurdsson · 2011 · Journal of Molecular Neuroscience
  55. NMR Meets Tau: Insights into Its Function and Pathology
    Guy M. Lippens, Isabelle Landrieu, Caroline Smet‐Nocca, Isabelle Huvent, Neha S. Gandhi, Benoı̂t Gigant, Clément Despres, Haoling Qi, Juan M. Lopez · 2016 · Biomolecules
  56. Mechanisms of protein homeostasis in health, aging and disease
    Pierre Goloubinoff · 2016 · Swiss Medical Weekly
  57. Assessment of the efficacy of different procedures that remove and disassemble alpha-synuclein, tau and A-beta fibrils from laboratory material and surfaces
    Alexis Fenyi, Audrey Coens, Tracy Bellande, Ronald Melki, Luc Bousset · 2018 · Scientific Reports
  58. Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and Unknowns
    David M. Asher, Ermias D. Belay, Eileen H. Bigio, Sebastian Brandner, Scott A. Brubaker, Byron W. Caughey, Brychan Clark, Inger K. Damon, Marc I. Diamond, Michelle P. Freund et al. · 2020 · Journal of Neuropathology & Experimental Neurology
  59. Pharmacological Modulators of Tau Aggregation and Spreading
    Antonio Dominguez‐Meijide, Eftychia Vasili, Tiago F. Outeiro · 2020 · Brain Sciences
  60. Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound
    Liyu Chen, Esteban Cruz, Lotta E. Oikari, Pranesh Padmanabhan, Jae Hee Song, Jürgen Götz · 2022 · Advanced Drug Delivery Reviews
  61. Spread of pathological human Tau from neurons to oligodendrocytes and loss of high-firing pyramidal neurons in aging mice
    Tim J. Viney, Barbara Sárkány, A. Tugrul Ozdemir, Katja Hartwich, Judith V. Schweimer, David M. Bannerman, Péter Somogyi · 2022 · Cell Reports
  62. Delineating the membrane-disrupting and seeding properties of the TDP-43 amyloidogenic core
    Gerard Chun-Hao Liu, Bryan Po‐Wen Chen, Ting-Juan Ye, Chih‐Hsien Wang, Wenlung Chen, Hsien‐Ming Lee, Sunney I. Chan, Joseph Jen‐Tse Huang · 2013 · Chemical Communications
  63. Intracellular and extracellular microtubule associated protein tau as a therapeutic target in Alzheimer disease and other tauopathies
    Jesús Ávila, Noemí Pallas‐Bazarra, Marta Bolós, Carmen Laura Sayas, Félix Hernández · 2015 · Expert Opinion on Therapeutic Targets
  64. From Prion Diseases to Prion-Like Propagation Mechanisms of Neurodegenerative Diseases
    Isabelle Acquatella-Tran Van Ba, Thibaut Imberdis, Véronique Perrier · 2013 · International Journal of Cell Biology
  65. Connectivity, not region-intrinsic properties, predicts regional vulnerability to progressive tau pathology in mouse models of disease
    Christopher Mezias, Eve LoCastro, Chuying Naomi Xia, Ashish Raj · 2017 · Acta Neuropathologica Communications
  66. Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers
    Christopher A. Olm, Corey T. McMillan, David John Irwin, Vivianna M. Van Deerlin, Philip A. Cook, James C. Gee, Murray Grossman · 2018 · NeuroImage Clinical
  67. Tau Protein and Frontotemporal Dementias
    Michel Goedert, Maria Grazia Spillantini, Benjamin Falcon, Wenjuan Zhang, Kathy L. Newell, Masato Hasegawa, Sjors H. W. Scheres, Bernardino Francesco Ghetti · 2021 · Advances in experimental medicine and biology
  68. Tau uptake by human neurons depends on receptor LRP1 and kinase LRRK2
    Lewis Evans, Alessio Strano, Eleanor J. Tuck, Ashley Campbell, James C. Smith, Christy Hung, Tiana S. Behr, Bernardino Francesco Ghetti, Benjamin Falcon, Emre Karakoç et al. · 2025 · The EMBO Journal
  69. Beyond Amyloid
    Rachel F. Lane, Diana W. Shineman, John Steele, Linda H Lee, Howard M. Fillit · 2012 · Advances in pharmacology
  70. BACE1-dependent cleavage of GABAA receptor contributes to neural hyperexcitability and disease progression in Alzheimer’s disease
    Danlei Bi, Hong Bao, Xiaoli Yang, Zujun Wu, Xiaoxu Yang, Guangwei Xu, Xiaoming Liu, Zhikun Wan, Jiachen Liu, Junju He et al. · 2025 · Neuron
  71. Prion-like Mechanisms in Alzheimer's Disease
    Ruihua Yin, Lan Tan, Teng Jiang, Jin‐Tai Yu · 2014 · Current Alzheimer Research
  72. The Interaction Between Sleep and Metabolism in Alzheimer’s Disease: Cause or Consequence of Disease?
    Carroll, Caitlin M., Macauley, Shannon L. · 2019 · Frontiers in Aging Neuroscience
  73. Evidence of corticofugal tau spreading in patients with frontotemporal dementia
    Eun‐Joo Kim, Jihye Hwang, Stephanie E. Gaus, Alissa L. Nana, Jersey Deng, Jesse A. Brown, Salvatore Spina, Myung Jun Lee, Eliana Marisa Ramos, Lea T. Grinberg et al. · 2019 · Acta Neuropathologica
  74. Prion-like properties of Tau assemblies
    Florence Clavaguera, Charles J. Duyckaerts, Stéphane Haı̈k · 2020 · Current Opinion in Neurobiology
  75. Cryo-EM structures of τ filaments from human brain
    Michel Goedert · 2021 · Essays in Biochemistry
  76. NMDA and AMPA Receptors at Synapses: Novel Targets for Tau and α-Synuclein Proteinopathies
    Maria Italia, Elena Silvia Ferrari, Mónica Di Luca, Fabrizio Gardoni · 2022 · Biomedicines
  77. Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates
    Morgane Darricau, Taxiarchis Katsinelos, Flavio Raschellà, Tomislav Milekovic, Louis Crochemore, Qin Li, Grégoire Courtine, William A. McEwan, Benjamin Dehay, Erwan Bézard et al. · 2022 · Brain
  78. Therapy for prion diseases: Insights from the use of RNA interference
    Melanie D. White, Giovanna R. Mallucci · 2009 · Prion
  79. Bioassays and Inactivation of Prions
    Kurt Giles, Amanda L. Woerman, David B. Berry, Stanley B. Prusiner · 2017 · Cold Spring Harbor Perspectives in Biology
  80. In Alzheimer's Disease, Hypometabolism in Low-Amyloid Brain Regions May Be a Functional Consequence of Pathologies in Connected Brain Regions
    Elisabeth Klupp, Stefan Förster, Timo Grimmer, Masoud Tahmasian, Igor Y. Yakushev, Christian Sorg, Behrooz H. Yousefi, Alexander E. Drzezga · 2014 · Brain Connectivity
  81. Tau immunization: a cautionary tale?
    Alexandra J. Mably, Daniel Kanmert, Jessica M. Mc Donald, Wen Liu, Barbara J. Caldarone, Cynthia Ann Lemere, Brian O’Nuallain, Kenneth S. Kosik, Dominic M. Walsh · 2014 · Neurobiology of Aging
  82. Insights into Mechanisms of Chronic Neurodegeneration
    Abigail B. Diack, James D. Alibhai, Rona M. Barron, Barry Matthew Bradford, Pedro Piccardo, Jean C. Manson · 2016 · International Journal of Molecular Sciences
  83. Tau Filaments and the Development of Positron Emission Tomography Tracers
    Michel Goedert, Yoshiki Yamaguchi, Sushil K. Mishra, Makoto Higuchi, Naruhiko Sahara · 2018 · Frontiers in Neurology
  84. Understanding the relationship between GSK-3 and Alzheimer’s disease: a focus on how GSK-3 can modulate synaptic plasticity processes
    Miguel Medina, Jesús Ávila · 2013 · Expert Review of Neurotherapeutics
  85. Cytosolic aggregates perturb the degradation of nontranslocated secretory and membrane proteins
    Oishee Chakrabarti, Neena S. Rane, Ramanujan S. Hegde · 2011 · Molecular Biology of the Cell
  86. Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus
    Farah Chali, Fathia Djelti, Emmanuel Eugène, Mario Valderrama, Catherine Marquer, Patrick R. Aubourg, Charles J. Duyckaerts, Richard Miles, Nathalie Cartier, Vincent Navarro · 2015 · European Journal of Neuroscience
  87. Biosynthesized metal nanoparticles as potential Alzheimer’s disease therapeutics
    Muhammad Ayaz, Muhammad Ovais, Irshad Ahmad, Abdul Sadiq, Ali Talha Khalil, Farhat Ullah · 2020 · Elsevier eBooks
  88. Shifts and drifts in prion science
    Adriano Aguzzi, Elena De Cecco · 2020 · Science
  89. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration
    Wheeler, Jeanna M., McMillan, Pamela J., Hawk, Michele, Iba, Michiyo, Robinson, Linda, Xu, George J., Dombroski, Beth A., Jeong, Doori, Dichter, Marc A., Juul, Halvor et al. · 2015 · Acta Neuropathologica Communications
  90. Propagation of the Prion Phenomenon: Beyond the Seeding Principle
    Christian Münch, Anne Bertolotti · 2012 · Journal of Molecular Biology
  91. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions
    Rona M. Barron, Declan King, Martin Jeffrey, Gillian McGovern, Sonya Agarwal, Andrew C. Gill, Pedro Piccardo · 2016 · Acta Neuropathologica
  92. Pathophysiology of Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Neuropsychiatric Clinical Expression
    Sharon Baughman Shively, David S. Priemer, Murray B. Stein, Daniel P. Perl · 2021 · Psychiatric Clinics of North America
  93. Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms
    Masato Hosokawa, Masami Masuda‐Suzukake, Hiroshi Shitara, Aki Shimozawa, Genjiro Suzuki, Hiromi Kondo, Takashi Nonaka, William D. Campbell, Tetsuaki Arai, Masato Hasegawa · 2021 · Brain
  94. Alzheimer’s Disease and Tau Self-Assembly: In the Search of the Missing Link
    Andrea González, Sandeep Kumar Singh, Macarena Churruca, Ricardo Benjamin Maccioni · 2022 · International Journal of Molecular Sciences
  95. Network anatomy in logopenic variant of primary progressive aphasia
    Maria Luisa Mandelli, Diego L. Lorca‐Puls, Sladjana Lukic, Maxime Montembeault, Andrea Gajardo‐Vidal, Abigail E. Licata, Aaron Scheffler, Giovanni Battistella, Stephanie M. Grasso, Rian Bogley et al. · 2023 · Human Brain Mapping
  96. Alzheimer's Disease and Prion Protein
    Jiayi Zhou · 2013 · Intractable & Rare Diseases Research
  97. Tau phosphorylation in hippocampus results in toxic gain-of-function
    Jesús Ávila, Elena Gómez de Barreda, Tobías Engel, José J. Lucas, Félix Hernández · 2010 · Biochemical Society Transactions
  98. Transcellular Spreading of Tau in Tauopathies
    Koen C. Demaegd, Joost W. H. Schymkowitz, Frédéric Rousseau · 2018 · ChemBioChem
  99. Could a Common Mechanism of Protein Degradation Impairment Underlie Many Neurodegenerative Diseases?
    David M. Smith · 2018 · Journal of Experimental Neuroscience
  100. Network models to enhance the translational impact of cross-species studies
    Julia K. Brynildsen, Kanaka Rajan, Michael X. Henderson, Dani S. Bassett · 2023 · Nature reviews. Neuroscience